CD63 and systemic lupus erythematosus: We further confirmed our observations by using ICs isolated from different SLE patients (n = 6) and HC subjected (n = 6), and measured the levels of pEVs (CD63+CD41+) release using ELISA-based analysis (Fig. 1K, P < 0.005).